Sara Busch
Nurse Practitioner · O Fallon, MONPI 1669007100
Payments from drug & device makers
Across 214 payments — averaging $18.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$732
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$479
- Johnson & Johnson$401
- Lilly USA, LLC$309
- Takeda Pharmaceuticals U.S.A., Inc.$278
- Aimmune Therapeutics, Inc.$171
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,67694%
- Education$2426%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 47 | $732 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $479 |
| Johnson & Johnson(2 entities) | 18 | $401 |
| Lilly USA, LLC | 16 | $309 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $278 |
| Aimmune Therapeutics, Inc. | 10 | $171 |
| QOL Medical, LLC | 8 | $170 |
| Ardelyx, Inc. | 10 | $166 |
| Intercept Pharmaceuticals, Inc. | 5 | $138 |
| Astellas Pharma US Inc | 3 | $128 |
| Sanofi | 5 | $109 |
| Bristol Myers Squibb | 5 | $90 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
| Biogen | 3 | $64 |
| Ironwood Pharmaceuticals, Inc | 3 | $61 |
| Phathom Pharmaceuticals, Inc. | 6 | $60 |
| Novo Nordisk | 3 | $47 |
| Biohaven Pharmaceuticals, Inc. | 3 | $46 |
| Amarin Pharma, Inc. | 3 | $39 |
| Mirum Pharmaceuticals, Inc. | 1 | $35 |
| UCB, Inc. | 2 | $35 |
| AstraZeneca | 2 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Eisai Inc. | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 2 | $26 |
| Boston Scientific | 1 | $24 |
| Boehringer Ingelheim | 1 | $21 |
| Merck | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $17 |
| Braintree Laboratories, Inc. | 1 | $16 |
| Bayer | 1 | $15 |
| GE HealthCare | 1 | $15 |
| Celltrion USA Inc. | 1 | $14 |
| Amgen | 1 | $13 |
| Novartis | 1 | $12 |
How this compares
$3,918 in reported general payments places this provider in the 90th percentile of 1,898 nurse practitioner providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in O Fallon
- Jennifer PhillipsO Fallon$15K
- Aeron SheffieldChesterfield$269K
- Rachel ImperatoOsage Beach$260K
- Matthew BrunsBridgeton$126K
- Michelle DickensSpringfield$59K
- Robert HafnerKansas City$47K
- Tracey CarpenterChesterfield$47K
- Laura GrantSaint Charles$34K
- Courtney JefferyKansas City$24K
- Carrie Roth BettlachSaint Louis$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.